·Basic Research·
Current
Issue· ·Achieve· ·Search Articles· ·Online
Submission· ·About IJO· PMC
Citation: Tian SW,
Ren Y, Pei JZ, Ren BC, He Y. Pigment epithelium-derived factor protects retinal
ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial
dysfunction. Int J Ophthalmol
2017; 10(7):1046-1054
Pigment epithelium-derived factor protects retinal
ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial
dysfunction
Shu-Wei Tian1,2, Yuan Ren1,
Jin-Zhi Pei1, Bai-Chao Ren2, Yuan He1
1Department of Ophthalmology, the Second Affiliated Hospital of
Xi’an Medical Univeristy, Xi’an 710038, Shaanxi Province, China
2Department of Ophthalmology, the Second Affiliated Hospital of
Xi’an Jiaotong University, Xi’an 710000, Shaanxi Province, China
Correspondence
to: Yuan He. Department of Ophthalmology, the Second Affiliated
Hospital of Xi’an Medical Univeristy, Xi’an 710038, Shaanxi Province, China.
openji7127@hotmail.com; Bai-Chao Ren. Department of Ophthalmology, the Second
Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710000, Shaanxi
Province, China. Dr.renbaichao@gmail.com
Received:
2016-09-30
Accepted: 2017-05-02
AIM: To
investigate the potential of pigment epithelium-derived factor (PEDF) to
protect the immortalized rat retinal ganglion cells-5 (RGC-5) exposed to CoCl2-induced
chemical hypoxia.
METHODS: After
being differentiated with staurosporine (SS), RGC-5 cells were cultured in four
conditions: control group cells cultured in Dulbecco 's modified eagle medium
(DMEM) supplemented with 10% fetal bovine serum, 100 μmol/mL
streptomycin and penicillin (named as normal conditions); hypoxia group cells
cultured in DMEM containing 300 μmol/mL
CoCl2; cells in the group protected by PEDF were first pretreated
with 100 ng/mL PEDF for 2h and then cultured in the same condition as hypoxia
group cells; and PEDF group cells that were cultured in the presence of 100
ng/mL PEDF under normal conditions. The cell viability was assessed by MTT
assay, the percentage of apoptotic cells was quantified using Annexin V-FITC
apoptosis kit, and intra-cellar reactive oxygen species (ROS) was measured by
dichloro-dihydro-fluorescein diacetate (DCFH-DA) probe. The
mitochondria-mediated apoptosis was also examined to further study the
underlying mechanism of the protective effect of PEDF. The opening of
mitochondrial permeability transition pores (mPTPs) and membrane potential (Δψm)
were tested as cellular adenosine triphosphate (ATP) level and glutathione
(GSH). Also, the expression and distribution of Cyt C and apoptosis inducing
factor (AIF) were observed.
RESULTS: SS
induced differentiation of RGC-5 cells resulting in elongation of their
neurites and establishing contacts between outgrowths. Exposure to 300 μmol/mL
CoCl2 triggered death of 30% of the total cells in cultures within
24h. At the same time, pretreatment with 100 ng/mL PEDF significantly
suppressed the cell death induced by hypoxia (P<0.05). The apoptosis
induced by treatment of CoCl2 was that induced cell death
accompanied with increasing intra-cellar ROS and decreasing GSH and ATP level.
PEDF pre-treatment suppressed these effects (P<0.05). Additionally,
PEDF treatment inhibited the opening of mPTPs and suppressed decreasing of Δψm
in RGC-5 cells, resulting in blocking of the mitochondrial apoptotic pathway.
CONCLUSION: Pretreatment
of RGC-5 cells with 100 ng/mL PEDF significantly decreases the extent of
apoptosis. PEDF inhibits the opening of mPTPs and suppresses decreasing of Δψm.
Moreover, PEDF also reduces ROS production and inhibits cellular ATP level’s
reduction. Cyt C and AIF activation in PEDF-pretreated cultures are also
reduced. These results demonstrate the potential for PEDF to protect RGCs
against hypoxic damage in vitro by preventing mitochondrial dysfunction.
KEYWORDS:
pigment epithelium-derived factor; CoCl2; retinal
ganglion cells-5; reactive oxygen species; reduced glutathione hormone;
mitochondrial permeability transition pores; membrane potential; adenosine
triphosphate; Cyt C; apoptosis-inducing factor
DOI:10.18240/ijo.2017.07.05
Citation: Tian SW, Ren Y, Pei JZ, Ren BC, He Y. Pigment
epithelium-derived factor protects retinal ganglion cells from hypoxia-induced
apoptosis by preventing mitochondrial dysfunction. Int J Ophthalmol 2017; 10(7):1046-1054
Death
of retinal ganglion cell (RGC) is a common feature of many eye diseases, such
as glaucoma, retinal ischemia, and optic neuropathy[1].
The RGCs death may involve various mechanisms, for example, reactive oxygen
species (ROS), nitric oxide, and excitatory amino acids[2-5]. It has been shown that RGCs die through apoptosis in
models of acute optic nerve lesion (axotomy and crush), experimental glaucoma
and human glaucoma[6-10].
In
humans, visual information entering the eye needs to be processed in the retina
before transmitted into visual center in brain via the optic nerve axons[11-12]. The RGCs transfer visual
information from the retina to the lateral geniculate nucleus (LGN), and
partially to another cortical region, including superior colliculus (SC),
coordinating eye movement. Like other neurons in the central nervous system
(CNS), RGCs fail to regenerate: once they die, they are lost forever. Thus,
glaucoma, as the view of a neurodegenerative disease, ultimately induces
irreversible change in neuronal function. Several risk factors have been
proposed to contribute to glaucoma progression, including elevated intraocular
pressure, age genetic background, thinner corneal thickness and vascular
dysregulation[13-19].
RGCs
death plays a key role in some ocular pathologies, such as retinal vessel
occlusion, diabetic retinopathy and glaucoma. The main cause of irreversible
neuronal injury and visual loss is ischemia which is a main trigger of RGCs
death and it is accompanied with many progressive changes, such as increase of
glutamate excite toxicity and free radical production, decrease of adenosine triphosphate (ATP) stores, ions imbalance, and apoptosis,
which eventually lead to RGCs death[20-21].
Importantly, reperfusion following ischemia may potentiate oxidative stress
that plays additional role in the RGCs degeneration[22].
Neurotrophins
are diffusible trophic molecules that exert a potent survival effect on adult
CNS neurons undergoing degeneration induced by variety of intrinsic and
extrinsic stimuli. Pigment epithelium-derived factor (PEDF) is a 50 kDa
glycoprotein that belongs to the superfamily of serine protease inhibitors,
secreted by retinal pigment epithelial (RPE) cells, which was first identified in
the conditioned medium of cultured fetal human RPE cells[23].
There are several reviews about PEDF functions in various aspects, such as
potent neuroprotective and neurotrophic activities, while its anti-angiogenic
effect was confirmed to participate in many aspects of ocular diseases
pathogenesis[24]. Several experimental results
indicate that after treatment of the ischemic retina with PEDF, the retinal
neurons can survive from the damage caused by ischemia. Notably, PEDF shows
dramatic effects on the neovascular response that is the feature of retinal
ischemia[25-28]. In addition, PEDF
acts as a survival factor for a wide range of cultured cells including
cerebellar granule cells, hippocampal neurons, and spinal cord motor neurons,
protecting these cells against glutamate toxicity and plays the role as an
antagonist of apoptosis[29-33].
Nevertheless, only few works about the function of PEDF on protecting the RGCs
under hypoxia have been reported. The exact mechanism of its protective action
is still need to be revealed.
In
the present study, we investigate the neuroprotective potential of PEDF on CoCl2-mimetic
hypoxia-induced apoptosis in rat retinal ganglion cells-5 (RGC-5) and explore
its possible mechanisms.
Cell
Culture The
transformed retinal ganglion cell line, RGC-5, was received from Zhong Shan
Medical Center. The cell line RGC-5 originally derives from postnatal day one
rat retinal cells transformed with Ψ2 E1A virus[34].
It was grown in high-glucose Dulbecco’s modified Eagle’s medium (DMEM; Hyclone,
USA) containing 10% fetal bovine serum (FBS; Hyclone, USA). RGC-5 cells were
cultured in a CO2 incubator (ESPEC, Japan) at 37℃ with 95% air and 5% CO2. The number of cells would be
doubled after 18-20h. We passaged cells at a ratio of 1:4 in every 2d. The
passages 10-20 of RGC-5 cells at 80%-90% confluence were used in all
experiments. RGC-5 was induced to differentiate into highly branched,
no-mitotic cells through the protocol developed by Frassetto et al[35]. Briefly, RGC-5 was firstly cultured as previously
described for 24h, then they were seeded into normal growth medium with only 1%
FBS (to slow the proliferation rate of the cells) containing staurosporine (SS)
316 nmol/L. After the treatment in this normal growth medium for 24h, the cells
were then processed for analysis.
CoCl2-mimetic
Hypoxia Injury CoCl2
was used to cultured cells to cause hypoxia. CoCl2 (Sigma, USA) was
dissolved in distilled H2O, and a 0.2-μm filter was used to make the
solution sterile. Based on the preliminary study, we pretreated cells with final concentration of 100 ng/mL PEDF in subsequent
experiments (PeproTech, USA) for 2h, and then treated them with 300 μmol/L CoCl2
for 24h.
Measurement
of Cell Viability Cells were
cultured in 96-well plates with density of 5×103 cells/well and 1%
FBS for 24h under various conditions: control group (C), hypoxia damage group
(H), PEDF pretreatment group (P+H), and PEDF group (P). Then MTT (5 mg/mL) was
added and incubated 4h, after that we used DMSO to dissolve the generated
formazan crystals. The absorbance of the crystalline at 490 nm was analyzed
with a Tecan Genios (Tecan, Germany). The cell viability of H group, P+H and P
groups were represented as the percentage of viable cells relative to cell
viability of the control group.
DAPI
Staining DAPI was
used to stain RGC-5 cells to visualize fragmented nuclei (Beyotime, China).
After being pretreated for 24h, cells were fixed with methanol for 10min
following stained with DAPI for 5min at room temperature. Finally, a
fluorescence microscope (SIV ZN, Japan) was used to detect RGC-5 cells.
Annexin
V-FITC/PI Assay Annexin
V-FITC/PI detection kit (Jiankangyuan, China) was used to detect apoptosis
following the manufacturer’s instructions. Briefly, the harvested cells were
resuspended in binding buffer with the density of 1×106 cells/mL.
Every 1×105 cells were mixed with 5 μL Annexin V-FITC and 10 μL PI.
The samples were kept in the dark at room temperature for 15min. Flow cytometry
(FACS-400, USA) was used to detect fluorescence. The percentage of apoptosis
was expressed with the number of Annexin V(+)/PI(-) cells and the number of
Annexin V(+)/PI(+) cells.
Assay
for Intracellular Reactive Oxygen Species
Intracellular redox state levels were detected using the
fluorescent dye dichloro-dihydro-fluorescein diacetate (DCFH-DA; GENMED, USA).
Briefly, we washed cells with phosphate buffered saline (PBS) once and
incubated in the PBS containing DCFH-DA for 30min at 37℃. Intracellular fluorescence was measured by flow cytometry
(FACS-400, USA).
Assessment
of Total Intracellular Glutathione The assay is
based on that glutathione (GSH) with dinitrothio cyanobenzene (DNTB; NJJC,
China) can form a kind of yellow compound. Briefly, after maintaining cell
cultures in the presence of different substances for 24h, approximately 1×106
cells were resolved. The cracked cells were added buffer solution and
centrifuged at 4000 rpm for 10min. Supernatant samples were transferred to a
microplate and added with DNTB, waiting for 5min detected 405 nm absorbance
using a Tecan Genios (Tecan, German).
Analysis
of Mitochondrial Membrane Potential
Lipophilic and cationic probe, JC-1 (Beyotime, China) was used for
the detection of the mitochondrial membrane potential (Δψm) of RGC-5 cells with
the fluorescent. Briefly, cells were seeded in 6-well plates, while incubating
with JC-1 staining solution (5 μg/mL) for 20min at 37℃ after appropriate treatments. After washing cells twice with JC-1
staining buffer, fluorescence intensity was detected by a flow cytometry
(FACS-400, USA). Mitochondrial JC-1 monomers and aggregates respectively showed
as green and red. The fluorescence ratio of red to green indirectly reflects the
Δψm of RGC-5 cells in different conditions.
Detection
of Opened Mitochondrial Permeability Transition Pores Opened
mitochondrial permeability transition pores (mPTPs) of RGC-5 cells was detected
by calcein-cobalt, which was included in a mPTP assay kit (GenMed Scientifics
Inc., USA). RGC-5 cells were seeded in 6-well plates (2.5×105 cells/well),
culturing 24h. After that, cells were treated with various conditions for 24h.
Cells were incubated with reagent B and C as ratio 1:50 for 20min at 37℃, following by washing with reagent A as described in the
manufacturer's instruction. After that, cells were washed twice again with
reagent A. Finally, the flow cytometry was used to detect fluorescence
intensity (FACS-400, USA).
Detection
of Cellular Adenosine Triphosphate Levels
We used firefly luciferase based ATP assay kit to measure cellular
ATP levels (Beyotime, China). Briefly, we pretreated RGC-5 cells with or
without PEDF, followed by 24h treatment of CoCl2. Cells were
harvested and centrifuged at 12 000× g for 5min. Every 100 μL ATP detection
working dilution was added in 100 μL supernatant, then mixed the components in
24-well plates. Luminance (RLU) represented the protein concentration, which
was measured by a Tecan Genios (Tecan, German). Each treatment group was
determined by generated standard curves. Total ATP levels were exhibited as
μmol/g protein.
Immunofluorescence
Analysis In order to
identify RGC-5, cells were cultured in a 6-well plate on coverslips, and then
treated with appropriate medium. After cells were 80%-90% confluent fixed with
4% paraformaldehyde, ruptured membrane with Triton X-100, 5% normal goat serum
was used for blocking at 37℃, then after
30min incubated with Thy-1 (Abcam, 1:500), Brn-3C (Sigma, 1:200), GFAP(Abcam,
1:3000), GABA-B (Millipore, 1:3000) and NMDA (Sigma, 1:200) respectively
overnight at 4℃ and
subsequently incubated with a combination of secondary antibodies goat
anti-chicken IgY (Abcam, 1:500) and FITC-anti-rabbit IgG (Kehao, China 1:100)
then stained with DAPI 5min. Finally, we examined the coverslips with a
fluorescence microscope (SIV ZN, Japan). Assay of expression of Cyt C and
apoptosis inducing factor (AIF) were carried on with same method as described
above.
Statistical
Analysis All
experiments were carried out three times independently. The results were
expressed in terms of mean±standard deviation (SD) values, and tested for statistical differences by analysis of variance, using the
one-way ANOVA method. When the calculated P value was <0.05, we take
the differences are significant.
Pigment
Epithelium-derived Factor Decreases Hypoxia-induced Apoptosis of Retinal
Ganglion Cells The purity
of RGC-5 cultures was confirmed by detecting expression of Thy-1, Brn-3c,
GABA-B receptor and NMDA in the cytoplasm and absence of glial marker GFAP
expression (Figure 1).
Figure
1 Cell identity.
To prove the
protective functions of PEDF on RGC-5 cells under the condition of hypoxia,
morphological changes of various treated RGC-5 cells were analyzed. In control
group, RGC-5 cells cultured in normal condition without any treatment exhibited
morphological characters of mature ganglion cells with long extensions. In the
hypoxia group, with prolonged exposure time, increased cells were observed
rounded up (Figure 2). MTT assays were used to quantitate cell viability. The
viability of RGC-5 cells decreased to 69%±1.5% after hypoxic exposure 24h,
while pretreated RGC-5
cells
with PEDF exhibited higher level of cell viability to 86%±3% (P<0.05 vs
H group). Notably, the viability of RGC-5 cells in C group and P+H group
exhibited no significant differences (Figure 3). We used DAPI-staining to
determine nuclear changes under various conditions of RGC-5 cells. RGC-5 cells
exposed to hypoxic condition expressed clear changes in chromatin morphology,
as condensation and fragmentation, exhibiting bright blue labeling, and the
changes were weakened by PEDF (Figure 4).
Figure
2 Phase-contrast micrographs of RGC-5 cells RGC-5 cells
were differentiated by staurosporine following exposed to hypoxia for 24h in
different groups. C: Control group; H: Hypoxia group; P+H: PEDF pretreated
group; P: PEDF group.
Figure
3 MTT assay Cell
viability of RGC-5 cells exposed to hypoxia for 24h in different group,
measured by MTT assay (aP<0.05 as compared to the C group;
cP<0.05 as compared to the H group).
Figure
4 DAPI staining Photomicrographs
of RGC-5 cells nuclear stained with DAPI (in different conditions).
Annexin
V-FITC/PI assay was also used for further analysis of the anti-apoptotic
effects of PEDF (Figure 5). Our data support the previous finding showed that
CoCl2 induce apoptosis of RGC-5 cells. The percentage of apoptotic
cells after 24h was significantly increased after CoCl2 treatment
(34.82%±2.17% vs 4.39%±1.23%, P<0.05). However, pretreatment
of these cells with PEDF decreased this number significantly (12.46%±0.31%, P<0.05).
It is thus clear that PEDF suppressed apoptosis of RGC-5 cells, which induced
by hypoxia.
Figure
5 Annexin V-FITC/PI staining Apoptotic
cells were counted as percentage via staining by Annexin V-FITC/PI and
analyzed with flow cytometry. The area of Annexin V(+)/PI(−) and Annexin
V(+)/PI(+) were included in apoptotic cells.
Hypoxia
Induced the Elevation of Intracellular Reactive Oxygen Species Increased
intracellular ROS in cells and tissues is a cause of damage in many
pathophysiological conditions. Plenty of work have documented that hypoxia
could induce the elevation of intracellular ROS[36].
In our study, we examined the role of ROS in the death of RGC-5 cells.
Consistent with earlier studies, an increasing level of ROS was observed in
RGC-5 cells exposed to hypoxic stress, 477.27±53.87 (P<0.05).
However, PEDF suppressed hypoxia-induced ROS increase in RGC-5 cells
(190.18±13.31, P<0.05) (Figure 6).
Figure
6 Intracellular ROS The effect
of PEDF on the ROS production in RGC-5 cells exposed to hypoxia. ROS was
measured using DCFH-DA cultures exposed to normoxia or hypoxia for 24h under
the condition with or without PEDF. Results are expressed as the means±SD. aP<0.05
compared to the C group; cP<0.05
compared to the H group.
We
carried out experiments to measure the level of cellular total anti-oxidant GSH
to further evaluate the effect of hypoxia on RGC-5 cells. As shown in Figure 7,
hypoxia decreased the GSH from 45.97±17.26 to 10.63±5.33 (P<0.05).
When the RGC-5 cells were pretreated with PEDF before the application of
hypoxia, no significant decrease of GSH was observed. There were no significant
differences between PEDF group and control group, indicating that the cellular
redox status is deteriorated when cells are exposed to the hypoxia, and PEDF
protects RGC-5 cells from it.
Figure
7 Intracellular GSH The effect
of PEDF on the intracellular GSH in RGC-5 cells exposed to hypoxia. Cells
culture exposed to normoxia or hypoxia for 24h in the presence or absence of
PEDF. Results are expressed as the means±SD. aP<0.05
compared to the C group; cP <0.05 compared to the H group.
Pigment
Epithelium-derived Factor Inhibits the Opening of Mitochondrial Permeability
Transition Pores Elevated Ca2+
level triggers the opening of mPTPs during hypoxia, then initiated mPTP
furthermore induces to mitochondrial dysfunction[37].
Therefore, distribution of green fluorescence, which emitted from calcein, was
monitored by the calcein-cobalt method as a result of intact mPTPs to examine
the influence of PEDF on mPTPs. After 24h induction of hypoxia, significantly
higher level of the opening of mPTPs in PEDF-treated cultures was observed in
fluorescence measurement (Figure 8), with the ratio of M2/M1 changing from
(0.47±0.17, P<0.05) in H group to (5.87±2.34) in H+P group. Our
results thus clearly demonstrated the ability of PEDF on reducing the extent of
opened mPTPs in hypoxic condition.
Figure
8 Opening of mPTPs The
normalized relative fluorescence units (NRFU) of calcein exhibit the
opening of mPTPs. RGC-5 cells were pretreated with or without
PEDF and exposed to normoxia or hypoxia for 24h. Results exhibit as the
means±SD. aP<0.05 compared to the C group, cP<0.05
compared to the H group.
Pigment
Epithelium-derived Factor Prevents Mitochondrial Dysfunction Δψm and
level of cellular ATP indicate mitochondrial activity. Therefore, we further
investigated the effects of PEDF on mitochondrial function based on the above
parameters. After 24h hypoxic exposure, RGC-5 cells exhibited lower Δψm values
(P<0.05). However, the Δψm of PEDF-treated cells and normal cells
showed no marked difference (Figure 9). Except the above index, cellular ATP
level also exhibits mitochondrial function. In this study, after 24h treatment
of hypoxia, cellular ATP level drastically decreased to 0.51±0.03 μmol/g
protein as Figure 10 shows. In contrast, pretreatment of cultured RGC-5 cells
with PEDF still contains relatively high cellular ATP content of 0.81±0.01
μmol/g protein (P<0.05). There were no marked differences between P
group and C group (Figure 10). Thus these findings directly demonstrated that
PEDF has the effect of protecting mitochondrial function during hypoxia.
Figure
9 Mitochondria Δψm Mitochondrial
Δψm of RGC-5 cells were determined using JC-1. RGC-5 cells were exposed to
normoxia or hypoxia for 24h in the condition with or without PEDF. Results show
as the mean±SD. aP<0.05 compared to the C group; cP<0.05
compared to the H group.
Figure
10 Cellular ATP Cellular ATP
concentration of RGC-5 cells were detected after exposed to normoxia or hypoxia
24h cultured with or without PEDF. Results are expressed as the mean±SD. aP<0.05
compared to the C group; cP <0.05 compared to the H group.
Pigment
Epithelium-derived Factor Affects Cyt C Involved Mitochondrial Apoptotic
Pathway Cyt C
entering to the cytoplasm mediates mitochondrial activation of apoptosis.
Importantly, we also observed a statistically significant difference between
the expression of Cyt C in the hypoxia group and the control group. During the
process of apoptosis, Cyt C dispersed while its concentration in cytosol
increased. The increase of red fluorescence in PEDF pretreated group is lower,
which indicates PEDF inhibits Cyt C releasing to cytoplasm from mitochondria
(Figure 11).
Figure
11 Expression and distribution of Cyt C
Effects of PEDF on the expression and distribution of Cyt C in
RGC-5 cells exposed to hypoxia for 24h. Cyt C immunoreactivity showed red in
RGC-5 with nuclear counter stained with DAPI (blue).
Pigment
Epithelium-derived Factor Affects Apoptosis Inducing Factor Apoptotic
Pathway We also
found difference between the expression of AIF in H group compared with C
group, and results showed that AIF dispersed in nucleus while its concentration
increased in cytosol. Weaker red fluorescent labeling in cytoplasm was observed
in PEDF group, which suggests that PEDF inhibits the release of AIF (Figure
12).
Figure
12 Expression and distribution of AIF Effects of PEDF on the expression and
distribution of AIF in RGC-5 exposed to hypoxia for 24h. The bright red
fluorescence indicates IF immunoreactivity (red) in RGC-5 cells.
Discussion
We
used the RGC-5 cell line to elucidate that PEDF can suppress hypoxia-induced
apoptosis in RGCs with the focus on mitochondrial function. Many endogenous
trophic factors have protective functions in models of neurodegenerative
diseases. Among them, PEDF is a cell survival factor secreted by the RPE and
widely expresses in most regions of nervous system[38-39]. The cytoprotective effects of PEDF have previously
been observed in cerebellar granule cells and retinal pericytes[40]. Reduced extracellular concentration of PEDF leads to
neuronal damage due to various cell-damaging conditions including hypoxia[41]. In our hypoxia model, PEDF preserved cells from
damage. We used 100 ng/mL PEDF on RGC-5 and found the total number of apoptotic
cells decreased from about 30% by 15%, meaning that PEDF obviously provides
neuroprotective effect. Furthermore, we used reliable methods to identify
apoptosis and viability of cells, including the Annexin V-FITC/PI assays to
detect apoptosis. Annexin V-FITC/PI assay showed that percentage of apoptotic
cells was 34.82%±2.17% vs 12.46%±0.31% (P<0.05) in C group and
P group respectively. The MTT assays also provided strong evidence for cell viability
to support our hypothesis that PEDF plays an important role in neuroprotective
effects on RGCs.
CoCl2
is a common agent to induce hypoxia is shown by the previous studies[42-43], and in our work using RGC-5,
we prove that CoCl2 contributes to hypoxia-induced damage. Gene and
protein expression are influenced by CoCl2 simulated hypoxia, which
is similar to ischemia[44]. CoCl2 induced
hypoxia breaks the balance of hypoxia-inducible factor-1 (HIF-1), between the
degradation and the consequent accumulation, thereby expression of heat shock
protein-27 increases[45]. Moreover, in CoCl2-treated
RGC-5 accumulation of HIF-1 protein also induces generation of β-amyloid
peptide. In addition, CoCl2 could active caspase-3/8, produce ROS
and fission anti-apoptotic protein Mcl-1 to induce apoptosis as shown
various in vitro studies[46-47]. And both in vivo
and in vitro studies show that RGCs are sensitive to oxidative
stress especially in pathological situations. In the experimental studies, CoCl2
is used in the hypoxia model and there are a lot of works providing
evidences that CoCl2 induces apoptosis while damaging retinal
photoreceptor[48-49].
ROS
plays an important role in retinal cells injury through changing cellular redox
potentials while reducing ATP levels, which indirectly induce apoptosis with
depleted GSH in diabetic retinopathy and glaucoma[50-52]. The imbalance between oxidative product and
anti-oxidants results in dysfunction and destruction of cells, and further
leads to tissue injury. Plenty of studies demonstrate that PEDF has a beneficial
aspect in protecting retinal endothelial cell from the increased ROS induced by
high glucose levels. In our study, we first describe the similar protective
function is also effective on RGC-5. CoCl2 significantly stimulates
the ROS activation (477.27±53.87), while pretreatment with PEDF could prevent
the ROS increasing (190.18±13.31, P<0.05). Here we evaluate the
possible connection between PEDF and mitochondria function. It is well known
that mitochondria is a key component for cells including RGCs. Mitochondrial
dysfunction plays an important role in hypoxia-induced apoptosis in RGCs.
Mitochondrial permeability transition is a critical factor in mediating
mitochondrial dysfunction. Morphological disintegration and functional damage
of mitochondria occur when the cell death is initiated[53].
From our current research, we provide further evidence that the anti-apoptotic
function of PEDF prevents mitochondrial dysfunction by suppressing the
mitochondrial permeability transition and obstructing the Cyt C apoptotic
pathway. During hypoxia, oxygen rapidly depletes then ATP levels decrease, thus
induce ionic gradients in cells are imbalance which lead to subsequent neuronal
depolarization. Mitochondrial permeability transition pores are non-specific
pores that connect the internal and outer membranes of mitochondria. The
molecule diameter up to about 1500 Da is allowed to cross the mitochondrial
membrane. Under the hypoxia situation, enormous amounts of Ca2+ flow
into cells, while adenine nucleotide depletes and cellular ROS levels elevate.
These trigger the opening of mPTPs, furthermore, mitochondrial permeability
transition occurs. Our observation that PEDF could suppress the opening of
mPTPs (5.87±2.34 vs 0.47±0.17, P<0.05) proves the protective
role of PEDF in the regulation of mPTPs.
Occurrence
of the mitochondrial permeability transition in a cell induces a series of
danger which directly threaten its survival, including bioenergetic,
biosynthetic, and redox[9,54].
The mitochondrial inner membrane is permeable to protons when the mitochondrial
permeability transition happens, uncoupling of the electron respiratory chain
occurs which results in the destruction of membrane potential, furthermore
induces stop generation of mitochondrial ATP[55].
The hypoxia-induced injury of mitochondrial Δψm and declined ATP level is
relieved on RGC-5, which are pretreated by PEDF. Our study supports
neuroprotection effect of PEDF in the view of preventing mitochondrial
dysfunction. The results exhibit in this study also is consistent with previous
studies of cerebella granular cells exposed to glutamate. PEDF were
demonstrated has the capability in strengthening the mitochondrial activity of
cells[56].
Another
threatening consequence of altered mitochondrial permeability is the apoptotic
proteins release from the mitochondria into the cytosol[53-55]. Because of Cyt C is a critical component of the
electron transfer chain, mitochondrial function is damaged when the
mitochondrial permeability transition is triggered and Cyt C releases from the
mitochondria into the cytosol. In this research, comparing to the cells
cultured in hypoxia medium, there is relatively lower cytosolic Cyt C level in
PEDF-pretreated cultures, thus proves that there is correlation between PEDF
and the protection of mitochondrial function. Furthermore, once Cyt C enters
the cytosol, apoptotic peptidase activating factor 1 (Apaf-1) and dATP are
activated to assemble an apoptosome. Moreover, apoptosome collects and
activates procaspase-9, which further leads to activation of other downstream
caspase to launch apoptosis[55].
AIF
causes nuclear chromatin condensation and further affects mitochondria, leading
to a drop in the ∆ψm and triggering the release of Cyt C as shown by immunofluorescence
staining[57-59]. Moreover, the
translocation of AIF occurs in the process of cell death in vivo, in
models of retinal degeneration. AIF releasing from mitochondria appears to
universally associate with cell death. Here we showed elevation of AIF in the
RGC-5 in the hypoxic condition and its decrease following protection with PEDF.
Although
the underlying mechanisms are not very clear and require further study, the
data from our study clearly demonstrate that PEDF plays an important role in
preventing signaling pathways of apoptosis.
In
conclusion, our study provides evidence that PEDF can protect RGC-5 from
hypoxia-induced mitochondrial dysfunction while inhibiting apoptosis. Its
effects include inhibiting the opening of mPTPs and suppressing the decrease of
Δψm. Moreover, PEDF also reduces ROS production and inhibited cellular ATP
level’s reduction which are important index of mitochondrial dysfunction. And
the research elucidates PEDF has an effect on inhibiting release of apoptogenic
protein. At the same time, PEDF, as a neurotrophins to be new treatment, still
requires further in vivo studies to ensure the efficiency of therapy in
protecting functions on RGCs. PEDF as a highly attractive treatment application
in the ophthalmic clinic, the long-term effects in retinal diseases have to be
investigated.
Foundation:
Supported by National Natural Science Foundation of China
(No.81100665).
Conflicts
of Interest: Tian SW, None; Ren Y, None; Pei JZ, None; Ren
BC, None; He Y, None.
1 Kawasaki A, Kardon RH. Disorders of the pupil. Ophthalmol Clin North Am 2001;14(1):149-168.
[PubMed]
3 Almasieh M, Wilson AM, Morquette B, Cueva Vargas JL,
Di Polo A. The molecular basis of retinal ganglion cell death in glaucoma. Prog Retin Eye Res 2012;31(2):152-181. [CrossRef]
[PubMed]
4 Qu J, Wang D, Grosskreutz CL. Mechanisms of retinal
ganglion cell injury and defense in glaucoma. Exp Eye Res 2010;91(1):48-53. [CrossRef] [PMC free article] [PubMed]
5 Chang EE, Goldberg JL. Glaucoma 2.0:
neuroprotection, neuroregeneration, neuroenhancement. Ophthalmology 2012; 119(5):979-986. [CrossRef]
[PMC free article] [PubMed]
6 Galindo-Romero C, Aviles-Trigueros M, Jimenez-Lopez
M, Valiente-Soriano FJ, Salinas-Navarro M, Nadal-Nicolas F, Villegas-Perez MP,
Vidal-Sanz M, Agudo-Barriuso M. Axotomy-induced retinal ganglion cell death in
adult mice: quantitative and topographic time course analyses. Exp Eye Res 2011;92(5):377-387. [CrossRef]
[PubMed]
7 Kalesnykas G, Oglesby EN, Zack DJ, Cone FE,
Steinhart MR, Tian J, Pease ME, Quigley HA. Retinal ganglion cell morphology
after optic nerve crush and experimental glaucoma. Invest Ophthalmol Vis Sci 2012; 53(7):3847-3857. [CrossRef] [PMC free article] [PubMed]
8 Doh SH, Kim JH, Lee KM, Park HY, Park CK. Retinal
ganglion cell death induced by endoplasmic reticulum stress in a chronic
glaucoma model. Brain Res 2010;1308:158-166. [CrossRef]
[PubMed]
9 Gemenetzi M, Yang Y, Lotery AJ. Current concepts on
primary open-angle glaucoma genetics: a contribution to disease pathophysiology
and future treatment. Eye (Lond)
2012;26(3):355-369. [CrossRef]
[PMC free article] [PubMed]
10 Baltmr A, Duggan J, Nizari S, Salt TE, Cordeiro MF.
Neuroprotection in glaucoma-Is there a future role? Experimental Eye Research 2010; 91(5):554-566. [CrossRef]
[PubMed]
11 Lyon DC, Nassi JJ, Callaway EM. A disynaptic relay
from superior colliculus to dorsal stream visual cortex in macaque monkey. Neuron 2010;65(2):270-279. [CrossRef]
[PMC free article] [PubMed]
12 Dhande OS, Huberman AD. Retinal ganglion cell maps
in the brain: implications for visual processing. Curr Opin Neurobiol 2014;24(1):133-142. [CrossRef]
[PMC free article] [PubMed]
13 The Advanced Glaucoma Intervention Study (AGIS): 7.
The relationship between control of intraocular pressure and visual field
deterioration. The AGIS Investigators. Am
J Ophthalmol 2000;130(4):429-440. [CrossRef]
14 Gordon MO, Beiser JA, Brandt JD, Heuer DK,
Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR,
Kass MA. The Ocular Hypertension Treatment Study: baseline factors that predict
the onset of primary open-angle glaucoma. Arch
Ophthalmol 2002;120(6):714-720; discussion 829-830. [CrossRef]
[PubMed]
15 Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L,
Yang Z, Group E. Predictors of long-term progression in the early manifest
glaucoma trial. Ophthalmology 2007;114(11):1965-1972.
[CrossRef]
[PubMed]
16 Leske MC, Connell AM, Wu SY, Nemesure B, Li X,
Schachat A, Hennis A. Incidence of open-angle glaucoma: the Barbados Eye
Studies. The Barbados Eye Studies Group. Arch
Ophthalmol 2001;119(1):89-95. [PubMed]
17 Mukesh BN, McCarty CA, Rait JL, Taylor HR.
Five-year incidence of open-angle glaucoma: the visual impairment project. Ophthalmology 2002;109(6):1047-1051. [CrossRef]
18 Medeiros FA, Sample PA, Zangwill LM, Bowd C, Aihara
M, Weinreb RN. Corneal thickness as a risk factor for visual field loss in
patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol 2003; 136(5):805-813. [CrossRef]
19 Leske MC. Ocular perfusion pressure and glaucoma:
clinical trial and epidemiologic findings. Curr
Opin Ophthalmol 2009;20(2):73-78. [CrossRef] [PMC free article] [PubMed]
20 Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham
M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic
strategies. Prog Retin Eye Res 2004;23(1):91-147.
[CrossRef]
[PubMed]
21 Tezel G. Oxidative stress in glaucomatous
neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 2006;25(5):490-513. [CrossRef]
[PMC free article] [PubMed]
22 Nakajima Y, Inokuchi Y, Nishi M, Shimazawa M,
Otsubo K, Hara H. Coenzyme Q10 protects retinal cells against oxidative stress
in vitro and in vivo. Brain Res 2008;1226:226-233.
[CrossRef]
[PubMed]
23 Becerra SP, Dass CR, Yabe T, Crawford SE. Pigment
epithelium-derived factor: chemistry, structure, biology, and applications. J Biomed Biotechnol 2012;2012:830975. [CrossRef] [PMC free article] [PubMed]
24 Bouck N. PEDF: anti-angiogenic guardian of ocular
function. Trends Mol Med 2002;8(7):330-334.
[CrossRef]
25 Ogata N, Wang L, Jo N, Tombran-Tink J, Takahashi K,
Mrazek D, Matsumura M. Pigment epithelium derived factor as a neuroprotective
agent against ischemic retinal injury. Curr
Eye Res 2001;22(4):245-252. [CrossRef]
26 Stellmach V, Crawford SE, Zhou W, Bouck N.
Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic
agent pigment epithelium-derived factor. Proc
Natl Acad Sci U S A 2001;98(5):2593-2597. [CrossRef] [PMC free article] [PubMed]
27 Duh EJ, Yang HS, Suzuma I, Miyagi M, Youngman E,
Mori K, Katai M, Yan L, Suzuma K, West K, Davarya S, Tong P, Gehlbach P,
Pearlman J, Crabb JW, Aiello LP, Campochiaro PA, Zack DJ. Pigment
epithelium-derived factor suppresses ischemia-induced retinal
neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci 2002;43(3):821-829. [PubMed]
28 Takita H, Yoneya S, Gehlbach PL, Duh EJ, Wei LL,
Mori K. Retinal neuroprotection against ischemic injury mediated by intraocular
gene transfer of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2003;44(10):4497-4504. [CrossRef]
30 Barnstable CJ, Tombran-Tink J. Neuroprotective and
antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic
potential. Prog Retin Eye Res 2004;23(5):561-577.
[CrossRef]
[PubMed]
31 Amaral J, Becerra SP. Effects of human recombinant
PEDF protein and PEDF-derived peptide 34-mer on choroidal neovascularization. Invest Ophthalmol Vis Sci 2010;51(3):1318-1326.
[CrossRef]
[PMC free article] [PubMed]
32 Sanagi T, Yabe T, Yamada H. Adenoviral gene
delivery of pigment epithelium-derived factor protects striatal neurons from quinolinic
acid-induced excitotoxicity. J
Neuropathol Exp Neurol 2010;69(3):224-233. [CrossRef]
[PubMed]
33 Bilak MM, Becerra SP, Vincent AM, Moss BH, Aymerich
MS, Kuncl RW. Identification of the neuroprotective molecular region of pigment
epithelium-derived factor and its binding sites on motor neurons. J Neurosci 2002;22(21):9378-9386. [PubMed]
34 Krishnamoorthy RR, Agarwal P, Prasanna G, Vopat K,
Lambert W, Sheedlo HJ, Pang IH, Shade D, Wordinger RJ, Yorio T, Clark AF,
Agarwal N. Characterization of a transformed rat retinal ganglion cell line. Brain Res Mol Brain Res 2001;86(1-2):1-12.
[CrossRef]
35 Frassetto LJ, Schlieve CR, Lieven CJ, Utter AA,
Jones MV, Agarwal N, Levin LA. Kinase-dependent differentiation of a retinal
ganglion cell precursor. Invest
Ophthalmol Vis Sci 2006;47(1):427-438. [CrossRef] [PubMed]
36 Guo M, Song LP, Jiang Y, Liu W, Yu Y, Chen GQ.
Hypoxia-mimetic agents desferrioxamine and cobalt chloride induce leukemic cell
apoptosis through different hypoxia-inducible factor-1alpha independent
mechanisms. Apoptosis 2006;
11(1):67-77. [CrossRef]
[PubMed]
37 Zoratti M, Szabo I, De Marchi U. Mitochondrial
permeability transitions: how many doors to the house? Biochim Biophys Acta 2005;1706(1-2):40-52. [CrossRef]
[PubMed]
39 Sheikpranbabu S, Haribalaganesh R, Gurunathan S.
Pigment epithelium- derived factor inhibits advanced glycation
end-products-induced cytotoxicity in retinal pericytes. Diabetes Metab 2011;37(6):505-511. [CrossRef]
40 Yabe T, Wilson D, Schwartz JP. NFkappaB activation
is required for the neuroprotective effects of pigment epithelium-derived
factor (PEDF) on cerebellar granule neurons. J Biol Chem 2001;276(46):43313-43319. [CrossRef] [PubMed]
41 Unterlauft JD, Eichler W, Kuhne K, Yang XM, Yafai
Y, Wiedemann P, Reichenbach A, Claudepierre T. Pigment epithelium-derived
factor released by Muller glial cells exerts neuroprotective effects on retinal
ganglion cells. Neurochem Res 2012;37(7):1524-1533.
[CrossRef]
[PMC free article] [PubMed]
42 Zhu X, Zhou W, Cui Y, Zhu L, Li J, Feng X, Shao B,
Qi H, Zheng J, Wang H, Chen H. Pilocarpine protects cobalt chloride-induced apoptosis
of RGC-5 cells: involvement of muscarinic receptors and HIF-1 alpha pathway. Cell Mol Neurobiol 2010;30(3):427-435. [CrossRef]
[PubMed]
43 Tsui L, Fong TH, Wang IJ. YC-1 targeting of
hypoxia-inducible factor-1alpha reduces RGC-5 cell viability and inhibits cell
proliferation. Mol Vis 2012;18:1594-1603.
[PMC free article] [PubMed]
44 Caltana L, Merelli A, Lazarowski A, Brusco A.
Neuronal and glial alterations due to focal cortical hypoxia induced by direct
cobalt chloride (CoCl2) brain injection. Neurotox Res 2009;15(4):348-358. [CrossRef]
[PubMed]
45 Yang SJ, Pyen J, Lee I, Lee H, Kim Y, Kim T. Cobalt
chloride-induced apoptosis and extracellular signal-regulated protein kinase
1/2 activation in rat C6 glioma cells. J
Biochem Mol Biol 2004;37(4):480-486. [CrossRef]
46 Merelli A, Caltana L, Girimonti P, Ramos AJ,
Lazarowski A, Brusco A. Recovery of motor spontaneous activity after intranasal
delivery of human recombinant erythropoietin in a focal brain hypoxia model
induced by CoCl2 in rats. Neurotox
Res 2011;20(2):182-192. [CrossRef]
[PubMed]
47 Hara A, Niwa M, Aoki H, Kumada M, Kunisada T, Oyama
T, Yamamoto T, Kozawa O, Mori H. A new model of retinal photoreceptor cell
degeneration induced by a chemical hypoxia-mimicking agent, cobalt chloride. Brain Res 2006;1109(1):192-200. [CrossRef]
[PubMed]
48 Whitlock NA, Agarwal N, Ma JX, Crosson CE. Hsp27
upregulation by HIF-1 signaling offers protection against retinal ischemia in
rats. Invest Ophthalmol Vis Sci 2005;46(3):1092-1098.
[CrossRef]
[PubMed]
49 Brownlee M. Biochemistry and molecular cell biology
of diabetic complications. Nature 2001;414(6865):813-820.
[CrossRef]
[PubMed]
50 Hancock JT, Desikan R, Neill SJ. Does the redox
status of cytochrome C act as a fail-safe mechanism in the regulation of
programmed cell death? Free Radic Biol
Med 2001;31(5):697-703. [CrossRef]
51 West IC. Radicals and oxidative stress in diabetes.
Diabet Med 2000;17(3):171-180. [CrossRef]
52 Kristian T. Metabolic stages, mitochondria and
calcium in hypoxic/ischemic brain damage. Cell
Calcium 2004;36(3-4):221-233. [CrossRef]
[PubMed]
53 Armstrong JS. The role of the mitochondrial
permeability transition in cell death. Mitochondrion
2006;6(5):225-234. [CrossRef]
[PubMed]
54 Galluzzi L, Morselli E, Kepp O, Kroemer G.
Targeting post-mitochondrial effectors of apoptosis for neuroprotection. Biochim Biophys Acta 2009;
1787(5):402-413. [CrossRef]
[PubMed]
55 El Idrissi A. Taurine increases mitochondrial
buffering of calcium: role in neuroprotection. Amino Acids 2008;34(2):321-328. [CrossRef] [PubMed]
56 Loeffler M, Daugas E, Susin SA, Zamzami N, Metivier
D, Nieminen AL, Brothers G, Penninger JM, Kroemer G. Dominant cell death
induction by extramitochondrially targeted apoptosis-inducing factor. FASEB J 2001;15(3):758-767. [CrossRef] [PubMed]
57 Susin SA, Daugas E, Ravagnan L, Samejima K, Zamzami
N, Loeffler M, Costantini P, Ferri KF, Irinopoulou T, Prevost MC, Brothers G,
Mak TW, Penninger J, Earnshaw WC, Kroemer G. Two distinct pathways leading to
nuclear apoptosis. J Exp Med 2000;192(4):571-580.
[CrossRef]
58 Ferri KF, Jacotot E, Blanco J, Este JA, Zamzami N,
Susin SA, Xie Z, Brothers G, Reed JC, Penninger JM, Kroemer G. Apoptosis
control in syncytia induced by the HIV type 1-envelope glycoprotein complex:
role of mitochondria and caspases. J Exp
Med 2000;192(8):1081-1092. [CrossRef]
59 Norberg E, Orrenius S, Zhivotovsky B. Mitochondrial
regulation of cell death: processing of apoptosis-inducing factor (AIF). Biochem Biophys Res Commun 2010;396(1):95-100.
[CrossRef]
[PubMed]